| 000 | 01676 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517013448.0 | ||
| 264 | 0 | _c20151201 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1873-7064 | ||
| 024 | 7 |
_a10.1016/j.neuropharm.2015.01.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Xiaoqun | |
| 245 | 0 | 0 |
_aDopamine depletion of the striatum causes a cell-type specific reorganization of GluN2B- and GluN2D-containing NMDA receptors. _h[electronic resource] |
| 260 |
_bNeuropharmacology _cMay 2015 |
||
| 300 |
_a108-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenergic Agents _xtoxicity |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xtoxicity |
| 650 | 0 | 4 |
_aAscorbic Acid _xtoxicity |
| 650 | 0 | 4 |
_aBrain Injuries _xchemically induced |
| 650 | 0 | 4 |
_aCorpus Striatum _xcytology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine _xdeficiency |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Agents _xpharmacology |
| 650 | 0 | 4 |
_aExcitatory Postsynaptic Potentials _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 | _aPatch-Clamp Techniques |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xmetabolism |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
| 700 | 1 | _aChergui, Karima | |
| 773 | 0 |
_tNeuropharmacology _gvol. 92 _gp. 108-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2015.01.007 _zAvailable from publisher's website |
| 999 |
_c24563846 _d24563846 |
||